Education
About Us
Working with TipRanks
Follow Us
Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 617.14K | $ 557.71K | $ 989.04K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 609.98K | $ -1.14M | $ 925.26K | $ -94.12K | $ -315.00K |
| Operating Income | $ -3.95M | $ -2.90M | $ -3.43M | $ -4.67M | $ -4.96M |
| EBITDA | $ -4.53M | $ -2.89M | $ -3.36M | $ -4.62M | $ -4.64M |
| Net Income | $ -4.73M | $ -3.10M | $ -3.55M | $ -5.54M | $ -6.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 307.44K | $ 76.58K | $ 21.61K | $ 682.98K | $ 97.23K |
| Total Assets | $ 1.01M | $ 1.45M | $ 2.04M | $ 3.51M | $ 589.20K |
| Total Debt | $ 3.18M | $ 3.03M | $ 2.23M | $ 1.74M | $ 23.80M |
| Net Debt | $ 2.88M | $ 2.95M | $ 2.21M | $ 1.06M | $ 23.70M |
| Total Liabilities | $ 6.98M | $ 9.04M | $ 8.27M | $ 7.70M | $ 30.80M |
| Stockholders' Equity | $ -5.96M | $ -7.59M | $ -6.23M | $ -4.19M | $ -30.21M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.28M | $ -2.57M | $ -3.04M | $ -1.01M | $ -4.09M |
| Operating Cash Flow | $ -3.28M | $ -2.57M | $ -3.04M | $ -1.01M | $ -4.09M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 2.75M | $ 2.19M | $ 1.37M | $ 4.02M | $ 3.60M |
Provectus Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.